AXSOME THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.75 USD | +0.79% |
|
-2.07% | +15.28% |
Chart calendar Axsome Therapeutics, Inc.
d8d5c86ef96.Sj1K0iS6ExGQmH8inEUx-Txk6KDAX96cTCIeb-SUopk.IXJ9nmrxSXT9-RFs8DF9tgQH2OGDHb3bInMtBKjN_ewbVzCQauxDacrVJg~73de531b8ea0b9f565a35368ab1165e2
Upcoming events on Axsome Therapeutics, Inc.
Past events on Axsome Therapeutics, Inc.
| 2024-09-11 08:30 am | Baird Global Healthcare Conference |
| 2024-09-04 | Wells Fargo Healthcare Conference |
| 2024-09-04 04:50 pm | Morgan Stanley Healthcare Conference |
| 2024-08-05 08:00 am | Q2 2024 Earnings Call |
| 2024-08-05 07:00 am | Q2 2024 Earnings Release |
| 2024-06-11 | Goldman Sachs Global Healthcare Conference |
| 2024-06-07 09:00 am | Annual General Meeting |
| 2024-06-05 03:00 pm | William Blair Growth Stock Conference |
| 2024-06-05 12:00 pm | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster No: 200 |
| 2024-06-05 12:00 pm | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster N0: 390 |
| 2024-06-05 12:00 pm | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster No: 390 |
| 2024-06-04 12:00 pm | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster No: 324 |
| 2024-06-04 11:00 am | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster No: 325 |
| 2024-06-03 12:00 pm | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster No: 266 |
| 2024-05-30 12:30 pm | American Society of Clinical Psychopharmacology Meeting - Poster No:T38 |
| 2024-05-29 11:15 am | American Society of Clinical Psychopharmacology Meeting - Poster No:W17 |
| 2024-05-29 11:15 am | American Society of Clinical Psychopharmacology Meeting - Poster No:W40 |
| 2024-05-29 11:15 am | American Society of Clinical Psychopharmacology Meeting - Poster No:W47 |
| 2024-05-16 11:00 am | BofA Securities Health Care Conference |
| 2024-05-14 01:35 pm | RBC Capital Markets Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 50,0 47,0 6.48% | 271 268 0.91% | 378 | 640 | 1 066 |
|
EBITDA Million USD | Released Forecast Spread | -125 -121 -2.99% | -175 -158 -11.24% | -225 -166 -35.15% | -221 | 30,9 | 398 |
|
EBIT Million USD | Released Forecast Spread | -125 -128 2.23% | -180 -161 -11.76% | -232 -184 -26.09% | -251 | -60,8 | 269 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -130 -134 2.99% | -187 -178 -5.12% | -238 -194 -23.13% | -261 | -99,0 | 219 |
|
Net income Million USD | Released Forecast Spread | -130 -135 3.34% | -187 -178 -5.06% | -239 -194 -23.53% | -268 | -100 | 171 |
|
EPS USD | Released Forecast Spread | -3,47 -3,58 3.03% | -4,60 -4,40 -4.6% | -5,27 -4,25 -23.9% | -5,62 | -1,84 | 3,78 |
| Announcement Date | 01/03/22 | 27/02/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | Juni | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,8 17,1 -1.24% | 24,4 21,7 12.06% | 94,6 26,3 259.35% | 46,7 40,9 14.05% | 57,8 54,9 5.35% | 71,5 69,0 3.61% | 75,0 72,9 2.95% | 87,2 86,9 0.27% | 99,9 | 115 | 117 | 137 | 163 | 203 |
|
EBITDA Million USD | Released Forecast Spread | -40,8 -36,6 -11.49% | -58,2 -43,5 -33.98% | -96,5 -55,1 -75.08% | -62,4 | -76,3 -63,3 -20.66% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -42,5 -40,3 -5.42% | -59,9 -43,4 -38.1% | -6,37 -51,0 87.51% | -65,1 -53,5 -21.59% | -62,1 -55,0 -12.87% | -98,3 -52,6 -86.91% | -67,3 -55,6 -21.04% | -78,0 -60,9 -28.23% | -62,1 | -48,7 | -43,6 | -32,1 | -20,0 | 5,16 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -44,8 -45,3 1.01% | -61,2 -46,8 -30.85% | -8,64 -30,8 71.98% | -67,8 -54,1 -25.28% | -62,9 -57,6 -9.11% | -99,0 -54,1 -82.89% | -68,4 -57,3 -19.24% | -79,3 -63,4 -25.1% | -63,2 | -50,6 | -51,7 | -38,5 | -26,2 | -12,7 |
|
Net income Million USD | Released Forecast Spread | -44,8 -45,0 0.35% | -61,2 -48,4 -26.45% | -11,2 -38,3 70.71% | -67,2 -55,3 -21.49% | -62,2 -57,0 -9.06% | -98,7 -54,0 -82.55% | -68,4 -58,5 -16.9% | -79,3 -63,3 -25.39% | -64,9 | -52,4 | -51,1 | -39,1 | -26,1 | -13,0 |
|
EPS USD | Released Forecast Spread | -1,07 -1,09 1.63% | -1,41 -1,14 -23.83% | -0,26 -0,88 70.54% | -1,54 -1,24 -24.6% | -1,32 -1,23 -7.23% | -2,08 -1,16 -78.56% | -1,44 -1,23 -17.27% | -1,67 -1,33 -25.38% | -1,36 | -1,09 | -1,01 | -0,71 | -0,34 | 0,05 |
| Announcement Date | 07/11/22 | 27/02/23 | 09/05/23 | 07/08/23 | 06/11/23 | 20/02/24 | 06/05/24 | 05/08/24 | - | - | - | - | - | - |
More events
Past sector events for Axsome Therapeutics, Inc.
| 2024-09-09 04:05 pm | AVID BIOSERVICES, INC.: Q1 2025 Earnings Release |
| 2024-09-05 06:30 am | KALVISTA PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
| 2024-08-30 11:56 pm | SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-30 | TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL VACCINE INC.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL ENGINEERING INC.: Q2 2024 Earnings Release |
| 2024-08-29 07:32 am | CLINUVEL PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | AIM VACCINE CO., LTD.: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AXSM Stock
- Calendar Axsome Therapeutics, Inc.